July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Retinal oxygen saturation, vessel diameter and flicker response in eyes with different subtypes of neovascular age-related macular degeneration during aflibercept treatment
Author Affiliations & Notes
  • Alexandra-Stephanie Weinhandl
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
    Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria
  • Katharina Eibenberger
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
    Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria
  • Sandra Rezar
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
    Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria
  • Doreen Schmidl
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
  • Wolf Buehl
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
  • Gerhard Garhofer
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
  • Ursula Schmidt-Erfurth
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
  • Stefan Sacu
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
    Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships   Alexandra-Stephanie Weinhandl, None; Katharina Eibenberger, None; Sandra Rezar, None; Doreen Schmidl, None; Wolf Buehl, None; Gerhard Garhofer, None; Ursula Schmidt-Erfurth, Alcon Laboratories (C), Allergan (C), Bayer Healthcare (C), Boehringer (C), Novartis (C); Stefan Sacu, Bayer Healthcare (F)
  • Footnotes
    Support  This study was funded by a research grant from Bayer Austria Ges.m.b.H
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1445. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexandra-Stephanie Weinhandl, Katharina Eibenberger, Sandra Rezar, Doreen Schmidl, Wolf Buehl, Gerhard Garhofer, Ursula Schmidt-Erfurth, Stefan Sacu; Retinal oxygen saturation, vessel diameter and flicker response in eyes with different subtypes of neovascular age-related macular degeneration during aflibercept treatment. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1445. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the effect of intravitreal aflibercept monotherapy on arterial and venous oxygen saturation, retinal vessel diameter and flicker response in patients with treatment naive various subtypes of exsudative maculopathy.

Methods : Forty-four eyes of consecutive treatment-naïve patients with polypoidal choroidal vasculopathy (PCV, n=12), hemorrhagic choroidal neovascularization (hCNV, n=12), pigment epithelium detachment (PED, n=9) and retinal angiomatous proliferation (RAP, n=11) were included in this prospective analysis. All patients received three initial aflibercept 2mg/0.05ml injections (Eylea®) in monthly intervals (loading phase) and were subsequently treated until month 12. Measurements of arterial and venous oxygen saturation, retinal vessel diameters and flicker response were performed using the Dynamic Vessel Analyzer (DVA; IMEDOS, Jena, Germany).

Results : Patients received a mean of 6±2 intravitreal injection during the 12 months study period. Mean visual acuity was 65±16 and improved to 68±17 at final follow-up (p=0.4). Significant reduction of central retinal thickness resulted from 531±179 to 354±134µm (p<0.01). Arterial and venous diameters were 94±22 /131±19µm at baseline, 93±19 /130±18µm at month 6 and 95±18 /130±16µm at month 12 (p=0.9/ p=0.7; p=0.8/ p=0.9). The course of total arterial and venous oxygen saturation during treatment was 95±2 /78±7% at baseline, 93±3 /78±7% at month 6 and 95±2 /81±7% at month 12 (p=0.8/ p=0.003; p=0.2 /p=0.9). Flicker measurements showed mean arterial change of 1.2±5 at baseline, 2.7±4 at month 6 and 2.8±5 at month 12 (p=0.2) while a venous change of 4.5± at baseline, 5.0± at month 6 and 4.8± at final follow-up was observed.

Conclusions : During intravitreal aflibercept treatment oxygen saturation, vessel diameter and flicker response was stable in patients with different subtypes of exsudative maculopathy.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×